As the stock market continues to recover from the effects of the global pandemic, investors are looking for promising opportunities to grow their portfolios in 2021 and beyond. One sector that has been gaining attention is the pharmaceutical and biotech industry, particularly companies that specialize in developing treatments and vaccines for various diseases.
Stock picks, which are stocks of small-cap companies with high growth potential, are especially popular among investors who are looking for high-risk, high-reward opportunities. Here are some of the top stock picks for 2021 and beyond in the pharmaceutical and biotech sector:
1. Sorrento Therapeutics (NASDAQ: SRNE) – Sorrento Therapeutics is a biopharmaceutical company that is focused on developing innovative therapies for cancer, autoimmune diseases, and COVID-19. The company’s stock has seen significant growth in recent months due to its promising pipeline of treatments and vaccines.
2. Novavax Inc. (NASDAQ: NVAX) – Novavax is a biotechnology company that is working on developing a COVID-19 vaccine. The company’s stock has seen a strong performance in 2020 and is expected to continue its growth in 2021 as it progresses through clinical trials and seeks regulatory approval.
3. Inovio Pharmaceuticals Inc. (NASDAQ: INO) – Inovio Pharmaceuticals is a biotechnology company that is focused on developing DNA-based immunotherapies and vaccines. The company’s stock has shown strong growth potential as it continues to advance its pipeline of treatments for various diseases.
4. Aytu BioScience Inc. (NASDAQ: AYTU) – Aytu BioScience is a specialty pharmaceutical company that is focused on developing and commercializing products for urological and respiratory conditions. The company’s stock has been gaining attention due to its innovative treatments and strong growth potential.
5. BioNTech SE (NASDAQ: BNTX) – BioNTech is a German biotechnology company that is known for its collaboration with Pfizer to develop a COVID-19 vaccine. The company’s stock has seen significant growth in 2020 and is expected to continue its momentum in 2021 as it expands its pipeline of treatments for other diseases.
Investing in stocks can be risky, as these companies are often in the early stages of development and may face challenges in bringing their products to market. However, for investors who are willing to take on some risk in exchange for the potential for high returns, these top stock picks in the pharmaceutical and biotech sectors are worth considering for 2021 and beyond.